- Investing Ideas
- /
- Norwegian Pharmaceuticals & Biotech Undervalued based on future growth
Norwegian Pharmaceuticals & Biotech Undervalued based on future growth
Results
2
0 new
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
2 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
NAVA | NOK 25.90 | 0% | -29.4% | NOK 457.5m | NOK 37.00 | PE23.3x | E29.6% | n/a | ||
CRNA | NOK 0.72 | 1.1% | -90.1% | NOK 32.5m | NOK 2.00 | PE3.4x | E61.2% | n/a |
Page 1 of 1